Nuclease Probe Technologies Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Out of Business

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Out of Business

Nuclease Probe Technologies General Information

Description

Developer of rapid diagnostic assays designed to detect disease-associated nuclease activities. The company's products have a unique ability to offer rapid pathogen identification directly from the blood of patients suspected of having bloodstream infections and determine the appropriate antibiotic to treat the human patient with a process called phenotypic antibiotic susceptibility testing, enabling physicians to determine which antibiotic is effective in treating the patient and eliminate unnecessary delays in treatment.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 110 Canal Street, 4th Floor
  • Care Of M2D2
  • Lowell, MA 01852
  • United States
Primary Industry
Other Services (B2C Non-Financial)
Other Industries
Other Healthcare Technology Systems
Vertical(s)
Corporate Office
  • 110 Canal Street, 4th Floor
  • Care Of M2D2
  • Lowell, MA 01852
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nuclease Probe Technologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 11-Sep-2026 Completed Out of Business
1. Later Stage VC 05-Mar-2019 Completed Generating Revenue
To view Nuclease Probe Technologies’s complete valuation and funding history, request access »

Nuclease Probe Technologies Patents

Nuclease Probe Technologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022150283-A1 Sars-cov-2 detection Inactive 05-Jan-2021
CA-3160102-A1 Microbial detection platform Pending 05-Nov-2019
EP-4054592-A1 Microbial detection platform Inactive 05-Nov-2019
EP-4054592-A4 Microbial detection platform Inactive 05-Nov-2019
US-20220380828-A1 Microbial detection platform Inactive 05-Nov-2019 A61K31/546
To view Nuclease Probe Technologies’s complete patent history, request access »

Nuclease Probe Technologies Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nuclease Probe Technologies FAQs

  • When was Nuclease Probe Technologies founded?

    Nuclease Probe Technologies was founded in 2014.

  • Where is Nuclease Probe Technologies headquartered?

    Nuclease Probe Technologies is headquartered in Lowell, MA.

  • What is the size of Nuclease Probe Technologies?

    Nuclease Probe Technologies has 2 total employees.

  • What industry is Nuclease Probe Technologies in?

    Nuclease Probe Technologies’s primary industry is Other Services (B2C Non-Financial).

  • Is Nuclease Probe Technologies a private or public company?

    Nuclease Probe Technologies is a Private company.

  • What is Nuclease Probe Technologies’s current revenue?

    The current revenue for Nuclease Probe Technologies is .

  • How much funding has Nuclease Probe Technologies raised over time?

    Nuclease Probe Technologies has raised $500K.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process